Search





Search





Eylea HD Approved By FDA As First And Only Injectable Anti-Vegf With Dosing Intervals Up To 5 Months

ReutersApr 2, 2026 4:36 PM

April 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:

EYLEA HD® (AFLIBERCEPT) APPROVED BY FDA AS FIRST AND ONLY INJECTABLE ANTI-VEGF WITH DOSING INTERVALS UP TO 5 MONTHS FOR WET AGE-RELATED MACULAR DEGENERATION (WAMD) AND DIABETIC MACULAR EDEMA (DME)
REGENERON PHARMACEUTICALS INC - FDA TARGET ACTION DATE IN APRIL 2026 FOR EYLEA HD PREFILLED SYRINGE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Nike Stock Falls Below 50 Dollars Is It Still a Good Investment?

TradingKey - For much of early 2026, Nike (NKE) was under significant selling pressure, resulting in an accelerated selloff following its fiscal Q3 report, which resulted in the stock price being pushed below $50.

WTI Oil Price Forecast: Trump Personally Opened the Path to Above $120.00

TradingKey - WTI prices continued to surge today as the market reprices Middle East risk.

Trump National Address ‘About-Face,’ Bitcoin Slumps Back to $66,000

Trump’s major reversal on Iran sparked a nearly 3% drop in Bitcoin, with the upcoming non-farm payroll data becoming a key focus.

SpaceX Reported to File for IPO—Here Is Another Reason to Buy Amazon Stock

TradingKey - According to a report on Reuters, SpaceX has confidentially submitted an IPO to be the largest since the original record of $25 billion. SpaceX IPO would create another publicly traded company that focuses solely on providing customers with high-speed internet through the use of satelli

Amazon Talks to Acquire Globalstar: Can $9 Billion Deal Challenge SpaceX Starlink?

TradingKey - During after-hours trading on April 1, 2026, shares of satellite communications company Globalstar (GSAT) surged 24%, with its market capitalization briefly approaching $9 billion. The rally was triggered by an exclusive report from the Financial Times stating that e-commerce giant Amaz

Tradingkey

KeyAI

